To further verify the downregulation of RND3 expression in GBM, we compared the expression levels of RND3 protein (Fig.1D) and transcript (Fig.1E) in four pairs of patient-matched GBM specimens and the corresponding glioma ABTs. This evidence concerns the gene RND3 and central nervous system cancer.